MRES (Institute of Biomedical Research) Total Operating Expense: $52.39 Mil (TTM As of Dec. 2010)


What is Institute of Biomedical Research Total Operating Expense?

Institute of Biomedical Research MRES +8.11% Total Operating Expense is $52.39 Mil as of Dec. 2010.

Institute of Biomedical Research's Total Operating Expense for the three months ended in Dec. 2010 was $0.02 Mil. Institute of Biomedical Research's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2010 was $52.39 Mil.


Institute of Biomedical Research Total Operating Expense Related Terms


Institute of Biomedical Research Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Total Operating Expense Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Total Operating Expense
Get a 7-Day Free Trial 0.00 0.03 4.08 0.43 0.26

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.12 52.22 0.04 0.02

Institute of Biomedical Research Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $52.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $52.39 Mil mean?
Institute of Biomedical Research (MRES) has a Total Operating Expense of $52.39 Mil as of Dec. 2010. Total operating expense is the primary recurring expense associated with central operations. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Total Operating Expense too high?
Institute of Biomedical Research's current Total Operating Expense is $52.39 Mil.
How does Institute of Biomedical Research's Total Operating Expense compare to HSTC and NTRR?
Institute of Biomedical Research's Total Operating Expense of $52.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current Total Operating Expense is $52.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Total Operating Expense of $52.39 Mil. The current Total Operating Expense is $52.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Total Operating Expense is $52.39 Mil as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.